reversed-phase HPLC comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-01-25. Numbers and descriptions here follow the published literature rather than marketing material.
Published work involving this sequence spans actin-binding assays, cell-migration studies, wound-healing models, and cardiovascular or musculoskeletal experiments. Much of the biological rationale derives from in vitro systems and animal models, and the number of controlled human studies is small. Reported outcomes vary across preparations, doses, and routes, which complicates comparison between studies. Reviews generally describe the evidence base as preliminary rather than settled. Mechanistic explanations are often proposed by analogy to the parent protein rather than demonstrated directly.
TB-500 is a synthetic seven-amino-acid peptide with the sequence LKKTETQ, corresponding to residues 17 through 23 of the protein thymosin beta-4. The N-terminus is typically acetylated in the described form, giving a monoisotopic mass near 888.5 Da and an average mass of about 889 Da. The designation TB-500 is a catalogue label rather than a formal chemical name, and the same sequence appears in the literature under several alternative abbreviations. It is handled as a research reagent rather than a pharmaceutical product.
Interest in the compound comes largely from studies of the parent protein, which participates in actin sequestration, cell migration and tissue repair processes. Whether a short fragment reproduces those activities is a separate question that remains open in the published record. Many summaries describe mechanisms by analogy to thymosin beta-4 rather than from direct measurements on the fragment. Claims about activity should be treated as provisional unless a cited study specifies the exact peptide, its purity and the assay used.
TB-500 is a laboratory label applied to a short synthetic peptide that is widely described as a fragment of thymosin beta-4, an actin-binding protein present in most mammalian cells. Suppliers and review articles usually present TB-500 as the N-terminal region of that protein, but the exact sequence attached to the name is not consistent across sources. Some product descriptions list a seven-residue chain; others use the label loosely for the parent protein itself. Because of that variation, any technical discussion of TB-500 needs to state which sequence is meant.
Thymosin beta-4 contains 43 amino acids and has a reported molecular mass near 4963 Da. The short fragment most often associated with the TB-500 label, an acetylated chain beginning LKKTETQ, has a reported mass near 889 Da, so the two are easily separated in analytical work. Mass spectrometry and amino acid analysis can confirm which material is present in a given sample. Statements treating TB-500 and thymosin beta-4 as interchangeable are therefore imprecise, even though the two appear together in much of the same literature.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C38H68N10O14 | Acetylated heptapeptide form |
| Monoisotopic mass | 888.5 Da | Average mass about 889 Da |
| Appearance | White to off-white solid | Usually supplied as lyophilised powder |
| Solubility class | Highly water soluble | Also dissolves in aqueous buffers |
| Common synonyms | Tbeta4 fragment, thymosin beta-4 (17-23) | Refer to the same sequence |
Identity and purity checks for peptide material typically combine reversed-phase high-performance liquid chromatography with mass measurement, since retention time alone cannot confirm a sequence. Mass measurement verifies the expected molecular mass within instrument tolerance, while chromatographic peak area provides a purity estimate. Anti-doping analysis of urine uses related but more sensitive workflows, sometimes after solid-phase extraction. For research material, batch documentation, certificate content, and independent testing are common points of scrutiny, because supply chains outside pharmaceutical regulation vary widely in the paperwork they provide.
Reconstitution of a lyophilized peptide is normally done with sterile water or a suitable buffer under aseptic conditions. Adding solvent down the vial wall and allowing gentle dissolution instead of vigorous vortexing reduces the chance of aggregation, which can lower the effective concentration of the resulting solution. Concentrated stocks are usually diluted into working buffer shortly before use. Because no standard preparation protocol exists for TB-500 specifically, laboratories adapt general peptide handling practice, and reported results may reflect differing preparation choices.
Dry peptide powder is commonly kept at −20 °C in a desiccated container away from light, a practice that limits moisture uptake and oxidation. Once dissolved, solutions are generally held at 2–8 °C for short periods or frozen at −20 °C or lower for longer storage, with repeated freeze-thaw cycles avoided. Hydrolysis and oxidation are the main degradation routes for peptides in solution, and both accelerate at higher temperature or extreme pH. Published stability data specific to TB-500 are limited, so shelf life should be treated as uncertain.
Peptide bonds are susceptible to hydrolysis under extreme pH and to enzymatic cleavage if proteases are present. Heat, oxidising agents, and prolonged exposure to light also contribute to loss of material. Aggregation can occur at high concentrations or in certain buffer systems, and it may not be visible to the eye. Storage at -20 C or below is typical for both powder and aliquoted solutions, and desiccation of the powder is preferred.
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography together with mass spectrometry. The chromatogram provides a purity estimate as a percentage of total peak area, while the mass spectrum confirms that the observed mass matches the expected value. Amino acid analysis or tandem mass spectrometry sequencing can provide additional confirmation. Reported purity figures depend on the column, gradient, and detection wavelength, so values from different laboratories are not directly comparable without method details.
Lyophilised peptide is normally reconstituted with sterile water or a neutral buffer shortly before use. Because repeated freeze-thaw cycles can degrade the material, dividing a reconstituted solution into single-use aliquots is a common practice. Working solutions are usually kept cold and protected from light. The exact shelf life depends on concentration, buffer composition, and handling, so it is often determined empirically rather than assumed.
Purity is normally assessed by reversed-phase HPLC, with the main peak reported as a percentage of total peak area, while identity is confirmed by mass spectrometry. Electrospray and MALDI-TOF instruments are both used, and the observed mass is compared with the value calculated from the stated sequence. Ion-exchange or size-exclusion methods appear where aggregation or charge variants are of interest. Water content, counter-ion content and residual trifluoroacetate from purification are separate variables that can shift the measured mass and should be weighed when reading a certificate of analysis.
Research peptides are typically supplied as a white to off-white lyophilised powder in a sealed vial. The dry solid is more stable than a solution and is normally kept refrigerated or frozen until use. Dissolution is usually done in water, phosphate-buffered saline or a similar aqueous medium, depending on the assay. Because the material is hygroscopic and easily contaminated, opening vials in a low-humidity environment and recording the lot number before use are standard laboratory practices.
=== Other uses === Based upon five case reports, valproic acid may have efficacy in controlling the symptoms of the dopamine dysregulation syndrome that arise from the treatment of Parkinson's disease with levodopa. Valproate is not commonly used to prevent or treat migraine headaches, but it may be prescribed if other medications are not effective. The medication has been tested in the treatment of AIDS and cancer, owing to its histone-deacetylase-inhibiting effects. It has cardioprotective, kidney protective, antiinflammatory, and antimicrobial effects.
=== Alternative stop codons === There are variations on the standard genetic code, and alternative stop codons have been found in the mitochondrial genomes of vertebrates, Scenedesmus obliquus, and Thraustochytrium.
==== Rebuilding links with the West ==== In 1999, Libya began secret talks with the British government to normalize relations. In 2001, Gaddafi publicly condemned the September 11 attacks on the US by al-Qaeda, expressing sympathy with the victims and calling for Libyan involvement in the US-led war on terror against militant Islamism. His government continued suppressing domestic Islamism, at the same time as Gaddafi called for the wider application of sharia law. Libya also cemented connections with China and North Korea, being visited by Chinese President Jiang Zemin in April 2002. However, relations with China became strained in May 2006 due to a visit to Tripoli by Taiwanese President Chen Shui-bian. Influenced by the events of the Iraq War, in December 2003, Libya renounced its possession of weapons of mass destruction, decommissioning its chemical and nuclear weapons programs. Relations with the US improved as a result. British Prime Minister Tony Blair visited Gaddafi in March 2004; the pair developed close personal ties. In 2003, Libya paid US$2.7 billion to the families of the victims of the Lockerbie bombing as it was the condition the US and UK had made for terminating the remaining UN sanctions. Libya continued to deny any role in the bombing. In 2009, Gaddafi attempted to strong-arm global energy companies operating in Libya to cover Libya's settlement with the families of the victims of Lockerbie.
=== Escherichia coli === A popular system utilized is Escherichia coli because of its rapid growth rate (~20–30 minutes), capacity for continuous fermentation and relatively low cost. Additionally, yeast has the capacity to express a high relative volume of heterologous protein. Specifically, up to 30% of proteins produced in yeast can be the heterologous gene product. There also are safe strains of E. coli that have been successfully generated to scale up production. In addition to E. coli's attractive host properties, this host is incredibly popular due to researchers having a large amount of knowledge about its genetics, including the complete genomic sequence. However, issues arise either due to the sequence of the gene of interest and those that are due to the limitations of E. coli as a host. For example, proteins expressed in large amounts in E.coli tend to precipitate and aggregate, which then requires another denaturation, renaturation recovery method. Finally, E. coli is only optimally effective in specific conditions dependent on the gene being inserted.
In biochemical signaling, diacylglycerol functions as a second messenger signaling lipid, and is a product of the hydrolysis of the phospholipid phosphatidylinositol 4,5-bisphosphate (PIP2) by the enzyme phospholipase C (PLC) (a membrane-bound enzyme) that, through the same reaction, produces inositol trisphosphate (IP3). Although inositol trisphosphate diffuses into the cytosol, diacylglycerol remains within the plasma membrane, due to its hydrophobic properties. IP3 stimulates the release of calcium ions from the smooth endoplasmic reticulum, whereas DAG is a physiological activator of protein kinase C (PKC). The production of DAG in the membrane facilitates translocation of PKC from the cytosol to the plasma membrane.
Sources: en.wikipedia.org
=== EC 1.14.21 With NADH or NADPH as one donor, and the other dehydrogenated === EC 1.14.21.1: Now EC 1.14.19.64, (S)-stylopine synthase EC 1.14.21.2: Now EC 1.14.19.65, (S)-cheilanthifoline synthase EC 1.14.21.3: Now EC 1.14.19.66, berbamunine synthase EC 1.14.21.4: Now EC 1.14.19.67, salutaridine synthase EC 1.14.21.5: Now EC 1.14.19.68, (S)-canadine synthase EC 1.14.21.6: Now EC 1.14.19.20, Δ7-sterol 5(6)-desaturase EC 1.14.21.7: Now EC 1.14.19.69, biflaviolin synthase EC 1.14.21.8: Now EC 1.14.19.63, pseudobaptigenin synthase EC 1.14.21.9: Now EC 1.14.19.70, mycocyclosin synthase * EC 1.14.21.10: Now EC 1.14.19.71, fumitremorgin C synthase * EC 1.14.21.11: Now EC 1.14.19.72, (–)-pluviatolide synthase * EC 1.14.21.12: Now EC 1.14.19.73, (S)-nandinine synthase *
Integrative Biology 131: General Human Anatomy (Fall 2005) by Professor Marian Diamond. Complete videos of the 40 lectures at Anatomy & Physiology (UC-Berkeley) "Anatomy of the Human Body". 20th edition. 1918. Henry Gray. In public domain. Human anatomy in photo Terminologia Anatomica (names of anatomical features) on FIPAT site
=== Amino acid properties and environmental conditions === Amino acids commonly used for amino acid dating analysis are leucine, aspartic acid, valine, glutamic acid, and diastereomer isoleucine. The properties of the amino acid(s) chosen for analysis influence what kind of dating can be performed. Amino acid interconversion reactions happen at a variety of speeds: aspartic acid racemizes very quickly and hence is used for recent samples where high resolution is important, while valine and leucine take much longer to racemize and are more appropriate for older fossils. Additionally, these reaction rates are sensitive to temperature, to a degree depending on the specific interconversion reaction. The racemization rate of aspartic acid varies with small changes in temperature, while valine's racemization rate is less temperature dependent. Besides higher temperatures accelerating interconversion reactions, other environmental variables also impact reaction rates. Wetter environments produce faster reaction rates, and interconversion reactions may be catalyzed by the presence of acids, bases, or metal cations. The chosen host organisms or taxa also introduce bias into age estimates. Amino acids which are bound within peptides interconvert more slowly than those which are free or are occupying the terminal position of peptide chains. The degree of hydrolysis of peptides (and therefore the speed at which equilibrium approaches) increases with fossil age.
Habib Thiam - former president of the National assembly, former prime minister, Senegal. Habib Sy - former Minister of Agriculture, Senegal. Iba Der Thiam - Writer, Historian, former Minister of Education. Ibrahima Diallo (politician) – politician who served in the French Senate from 1956 to 1958 Dior Fall Sow - Senegalese jurist and legal scholar, First female prosecutor in Senegal. Khalifa Sall - former mayor of Dakar. Khadidiatou Diallo- Activist, Senegal Mata Sy Diallo - former vice president of the National Assembly. Maba Diakhou Ba – Religious leader, Nioro Senegal Mamadou Dia – Member of French Senate from 1948 to 1956 and the French National Assembly from 1956 to 1958. First Prime Minister of Senegal (1957–62), Senegal Mamadou Moustapha Ba - former Minister of Economy and Finance. Moussa Balde - Former Minister of National Education, Higher Education, Research and Innovation (MENESRI), Senegal. Yérim Habib Sow - Ivorian-Senegalese Entrepreneur, Founder Teyliom Group. Omar Sy – French actor and comedian Ousmane Sow – sculptor, Senegal Oumar Khassimou Dia - Former Minister of planning and Foreign affairs, senegal. Elhadj As Sy - former secretary general of International Federation of Red Cross and Red Crescent Societies. Fodé Seck - Senegalese Diplomat, former president of the UN Security Council. General Mountaga Diallo- former Force Commander of MONUC, former diplomat, Senegal Safiatou Thiam - former Minister of Health. Samba Ndiobène Ka - Former Minister of Agriculture, Rural Equipment and Food Sovereignty.
=== Poisoning of Emilian Gebrev === In the aftermath of the Skripal poisoning, investigative journalists were able to track some of the people involved also in Bulgaria. This is how another suspected poisoning case dating back to April 2015 during their stay in the country was linked to the Novichok nerve agent. The victim was the Bulgarian arms dealer Emilian Gebrev, who shared two hypotheses why he might have been attacked: The first one links to the fact that his arms manufacturing company Dunarit exports defense equipment to Ukraine. The other one relates to an attempt by an offshore company to take over Dunarit. The takeover attempt was ultimately linked to the influential Bulgarian politician and oligarch Delyan Peevski who has historically been funded by Russia's state-owned VTB Bank. In November 2023 Bulgaria sought the extradition of three Russian GRU officers, Sergey Fedotov, Georgi Gorshkov and Sergey Pavlov, suspected of the poisoning incident. Sergei Fedotov was also the alias used by one of the assassins in the Salisbury poisonings.
Sources: en.wikipedia.org
The report concluded that a final determination of the origin was unlikely without cooperation from the Chinese government, saying their prior lack of transparency "reflect[ed] in part China's government's own uncertainty about where an investigation could lead, as well as its frustration that the international community is using the issue to exert political pressure on China." Chinese foreign ministry spokesman Wang Wenbin said that the US intelligence report was "unscientific and has no credibility". On 23 May 2021, The Wall Street Journal reported that a previously undisclosed US intelligence report stated that three researchers from the Wuhan Institute of Virology became ill enough in November 2019 to seek hospital care. The report did not specify what the illness was. Officials familiar with the intelligence differed as to the strength to which it corroborates the hypothesis that the virus responsible for COVID-19 was leaked from the WIV. The WSJ report notes that it is not unusual for people in China to go to the hospital with uncomplicated influenza or common cold symptoms. Yuan Zhiming, director of the WIV's Wuhan National Biosafety Laboratory, responded in the Global Times, a Chinese state media outlet, that the "claims are groundless". Marion Koopmans, a member of the WHO study team, described the number of flu-like illnesses at the WIV in 2019 as "completely normal". Workers at the WIV must provide yearly serum samples. WIV virologist Shi Zhengli said in 2020 that, based on an evaluation of those serum samples, all staff tested negative for COVID-19 antibodies.
Club considers the duo's collaborations—which earned them the 2013 National Board of Review (Spotlight Award)—to be career-defining moments for both of them and as vital as Scorsese's acclaimed collaborations with Robert De Niro. Author Michael K. Hammond wrote that DiCaprio built his star reputation by demonstrating his acting ability, and praised him for "revealing a character while concealing the actor" and "disappearing into [his] roles". According to Agnieszka Holland, who directed DiCaprio in Total Eclipse (1995), DiCaprio is "one of the most mature actors" she has worked with and is "courageous" in his choice of roles. Holland remarked that he does not rely on method acting but rather on a trick that allows him to truly "become the character". His Marvin's Room co-star Meryl Streep said that DiCaprio possesses the kind of unpredictability that makes his career difficult to classify, his life precarious and his work thrilling. Analyzing DiCaprio's career, film critic Philip French identified a theme of "characters who are still in the process of becoming a man" and suggested that the actor's propensity for films about dysfunctional families and characters seeking father figures alludes to his own troubled childhood. DiCaprio often plays characters who themselves are playing roles, which Caryn James says looks simple on screen but requires sophisticated acting. He tends to play antiheroes and characters who lose their mental stability as the narrative progresses.
It is proposed that postural and spinal assessment, along with ergonomic assessments, should be considered, based on the observation that addressing these factors has been found to improve comfort in some studies, although experimental data are lacking, and the perceived benefits may not be specific to those interventions. A 2010 survey by NIOSH showed that two-thirds of the 5 million carpal tunnel diagnoses in the US that year were related to work. Women are more likely to be diagnosed with work-related carpal tunnel syndrome than men. Many if not most patients described in published series of carpal tunnel release are older and often not working. Normal pressure of the carpal tunnel has been defined as a range of 2–10 mm (0.079–0.394 in). Wrist flexion increases the pressure eight-fold and extension increases it ten-fold. There is speculation that repetitive flexion and extension in the wrist can cause thickening of the synovial tissue that lines the tendons within the carpal tunnel.
== Creationism == A Methodist from age ten, and later a fundamentalist Baptist, Gish believed that the Genesis creation narrative was historical fact. After reading the booklet Evolution, "Science Falsely So-called" in the late 1950s, Gish became persuaded that science had produced falsifiable evidence against evolutionary theory, particularly the origin of life, and that various fields of science offered corroborating evidence in support of the Genesis creation narrative. He joined the American Scientific Affiliation (ASA), an association of Christian scientists, mistakenly assuming the group supported creationism. Through his affiliation at the ASA, Gish met geneticist and creationist William J. Tinkle, who in 1961 invited Gish to join a newly formed anti-evolution caucus within the ASA. In 1971, Gish became a member of the faculty at San Diego Christian College, working in its research division before accepting a position at the Institute for Creation Research (independent since 1981). He was the author of several books and articles espousing creationism. His best-known work, Evolution: The Fossils Say No!, published in 1972, has been widely accepted by creationists as an authoritative reference. Gish initially "assigned low priority to the question of [the] age [of the Earth]". At his death on March 5, 2013, Gish held the position of Senior Vice-President Emeritus at the ICR.
Sources: en.wikipedia.org
No. TB-500 is a short synthetic peptide matching residues 17 to 23 of thymosin beta-4, while the parent protein contains 43 residues. The fragment lacks the rest of the protein sequence, so the two are related but not identical.
It consists of leucine, lysine, lysine, threonine, glutamic acid, threonine, and glutamine in that order. The N-terminal leucine is usually acetylated in the forms described in catalogues.
Controlled human data is limited, and most published findings come from cell culture or animal work. This makes it difficult to state clinical effects with confidence.
No. TB-500 is a trade-style label used for a synthetic peptide described as a fragment of thymosin beta-4, while thymosin beta-4 is the full 43-residue protein. The two differ in size and are not interchangeable terms in analytical work.